We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Live webcast on Wednesday, May 1st at 3:00 PM ET LA JOLLA, CA, April 25, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an...
Ongoing efforts to build a robust global patent estate for a growing pipeline targeting high-value indications in need of innovation Continued advancement of an innovative pipeline of NKT cell...
LA JOLLA, CA, April 08, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell...
Ongoing Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) with interim data expected H1 2024 and topline data expected H2 2024...
Live webcast on Wednesday, April 3rd at 10:10 AM ET LA JOLLA, CA, March 28, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing...
Company advancing an innovative pipeline of NKT cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases Ongoing efforts to build a robust global patent estate for a...
MHRA authorization expands ongoing U.S. Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (“IPF”) with interim data expected H1 2024 and...
LA JOLLA, CA, Feb. 02, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0782 | -14.8218347233 | 0.5276 | 0.59 | 0.4115 | 222340 | 0.48175954 | CS |
| 4 | -0.3266 | -42.087628866 | 0.776 | 0.7805 | 0.4115 | 150289 | 0.5246037 | CS |
| 12 | -1.1606 | -72.0869565217 | 1.61 | 1.73 | 0.4115 | 429386 | 0.97162962 | CS |
| 26 | -6.9006 | -93.8857142857 | 7.35 | 10.36 | 0.4115 | 602124 | 2.6040725 | CS |
| 52 | -52.6806 | -99.1541501976 | 53.13 | 62.2314 | 0.4115 | 337652 | 4.04406687 | CS |
| 156 | -91.9506 | -99.5136363636 | 92.4 | 93.31 | 0.4115 | 336447 | 4.28062572 | CS |
| 260 | -91.9506 | -99.5136363636 | 92.4 | 93.31 | 0.4115 | 336447 | 4.28062572 | CS |
Monksdream
2 months ago
littleharoldeh
2 months ago
tw0122
2 months ago
Monksdream
2 months ago
Monksdream
3 months ago
Invest-in-America
3 months ago
Awl416
3 months ago
IVANj
3 months ago
TheFinalCD
3 months ago
Renee
3 months ago
KOGT
6 months ago
Monksdream
7 months ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
